Cancer cell line developed that is resistant to new cancer therapy

	Tweet

They found the HDAC inhibitor-resistant cell line resistant to many therapies, including more standard treatment such as chemotherapy, but highly sensitive to heat shock protein 90, or hsp90, inhibitors, another emerging cancer treatment.

“As part of their resistance mechanisms, they acquired greater sensitivity to hsp90 inhibitors,” says Dr. Bhalla, Cecil F. Whitaker Jr., M.D./Georgia Research Alliance Eminent Scholar in Cancer.  “This creates a potential combination that can be tested in mouse models and ultimately clinical trials.”

HDAC and hsp90 inhibitors are both being studied in combination with other cancer therapies but not each other. However the MCG researchers, who already have published work indicating a synergistic effect, were not surprised by what they found.

“Resistance to HDAC inhibitors is going to emerge, so you need a cellular model to understand mechanisms of resistance and an in vivo model, a mouse model typically, to test new combinations you design based on studies in culture,” says Dr. Bhalla.

The researchers have put the cell line into a mouse model and other scientists already are asking for the resistant cell line, he says.

“This particular cell line can be used to really look at newer agents and new combinations in vitro and in vivo and see if they are safe and effective together,” Dr. Fiskus says.

Heat shock proteins are protein caretakers, activating genes that ultimately make proteins, move them around cells and fold them into shape for proper function. Misfolded proteins can cause cancer.

MCG is participating in an early-phase clinical trial of the oral HDAC inhibitor, LBH589, developed by Novartis Corp. Studies also are underway for some innovative uses of hsp90 inhibitors, including Dr. John Catravas’ studies of its potential as an anti-angiogenesis agent and Dr. Abdullah Kutlar’s studies to see if it can reduce morbidity and related lung problems in sickle cell disease by suppressing inflammation.

Toni Baker
Medical College of Georgia

RELATED STORIES:
Combining NSAIDs with chemotherapy, radiation may improve cancer treatment   Researchers present new findings on cancer and gene therapy   Smoking and hepatitis C up risk of lymphoma   Punctuated evolution in cancer genomes   Proteins Stop Blood-Vessel and Tumor Growth in Mice   How Eating Red Meat Can Spur Cancer Progression   Potential New Therapeutic Molecular Target to Fight Cancer   Team Identifies New Cancer Stem Cell Driving Metastatic Tumors   Can recycling be used to treat cancer?   Anti-Cancer Agent Stops Metastasis in Its Tracks   Study Quantifies Racial Disparities in Cancer Mortality Rates   Cancer patients want honesty, compassion from their oncologist   Normalizing Tumor Vessels to Improve Cancer Therapy   Study links infections with some childhood cancers   Jews who survived wartime Europe have more cancer   Researchers Discover Second Protective Role for Tumor-Suppressor   Cancer test delays force UK women into surgery   Chemotherapy Complications Greater than Previously Estimated   Rate of Secondary Cancers Increases Over Years After Treatment for Childhood Leukemia   Top cancer fighting foods   Drug Therapy to Bolster Immune System Cells Found Effective Toward Childhood Cancer   Patient knowledge of health information influences cancer treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]